Charges associated with the November 2008 purchase of Applied Biosystems brought our favorite Carlsbadistan-based life sciences company Life Technologies profits down to a quarterly loss of $106.9 million, according to a story on Genomeweb.com.
The Carlsbad, Calif.-based firm brought in total revenues of $540.6 million for the three-month period ended Dec. 31, compared to revenues of $336.4 million for Invitrogen alone in the 2007 fourth quarter. That tally fell short of analysts’ consensus estimate of revenues of $572.6 million for the quarter.
The stock opened today at $30.64 so it looks like everyone is pretty happy with the numbers anyway.
[Link: Genomeweb.com]
RSS Feed-Posts
{ 0 comments… add one now }